Evidence map›Paper›PMID 19042940›Full record

Trial reportThe Journal of antimicrobial chemotherapy2009

Cranberry or trimethoprim for the prevention of recurrent urinary tract infections? A randomized controlled trial in older women.

Marion E T McMurdo, Ishbel Argo, Gabby Phillips, Fergus Daly, Peter Davey

Registry-linked trialOpen access · bronzeAbstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in The Journal of antimicrobial chemotherapy, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04146103 (Prospective Multicenter Open-label One Arm Trial Investigating a Pumpkin Seed, Isoflavonoid and Cranberry Mix in Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia), which is not on this map. Cited by 46 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 4 pooled it
9.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04146103 nacompletednot on this mapstarted 2018, after this paper: background citation

Prospective Multicenter Open-label One Arm Trial Investigating a Pumpkin Seed, Isoflavonoid and Cranberry Mix in Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia

TypeinterventionalSponsorSaint-Joseph UniversityRan2018 to 2019Enrolled163ConditionsBenign Prostatic HyperplasiaArmsNovex
3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 4 syntheses or guidelines pooled it, 177 citations in OpenAlex.

  1. Cranberries for preventing urinary tract infections.The Cochrane database of systematic reviews · 2023
    Pooled it
  2. Cranberries for preventing urinary tract infections.The Cochrane database of systematic reviews · 2023
    Pooled it
  3. Pooled it
  4. Cranberries for preventing urinary tract infections.The Cochrane database of systematic reviews · 2012
    Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Cranberry juice fails to prevent recurrent urinary tract infection: results from a randomized placebo-controlled trial.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2011
    Trial
  10. Review
  11. Review
  12. Antibiotic prophylaxis for urinary tract infection.Canadian family physician Medecin de famille canadien · 2022
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Natural therapeutics for urinary tract infections-a review.Future journal of pharmaceutical sciences · 2020
    Review
  18. Article
  19. Review
  20. Challenges of a one-health approach to the development of alternatives to antibiotics.Animal frontiers : the review magazine of animal agriculture · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Marion E T McMurdoAgeing and Health, Division of Medicine and Therapeutics, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, Scotland, UK. m.e.t.mcmurdo@dundee.ac.uk
Ishbel Argo
Gabby Phillips
Fergus Daly
Peter Davey
Ninewells Hospital · GBUniversity of Dundee · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo compare the effectiveness of cranberry extract with low-dose trimethoprim in the prevention of recurrent urinary tract infections (UTIs) in older women. PATIENTS AND

methodsOne hundred and thirty-seven women with two or more antibiotic-treated UTIs in the previous 12 months were randomized to receive either 500 mg of cranberry extract or 100 mg of trimethoprim for 6 months.

resultsThirty-nine of 137 participants (28%) had an antibiotic-treated UTI (25 in the cranberry group and 14 in the trimethoprim group); difference in proportions relative risk 1.616 (95% CI: 0.93, 2.79) P = 0.084. The time to first recurrence of UTI was not significantly different between the groups (P = 0.100). The median time to recurrence of UTI was 84.5 days for the cranberry group and 91 days for the trimethoprim group (U = 166, P = 0.479). There were 17/137 (12%) withdrawals from the study, 6/69 (9%) from the cranberry group and 11/68 (16%) from the trimethoprim group (P = 0.205), with a relative risk of withdrawal from the cranberry group of 0.54 (95% CI: 0.19, 1.37).

conclusionsTrimethoprim had a very limited advantage over cranberry extract in the prevention of recurrent UTIs in older women and had more adverse effects. Our findings will allow older women with recurrent UTIs to weigh up with their clinicians the inherent attractions of a cheap, natural product like cranberry extract whose use does not carry the risk of antimicrobial resistance or super-infection with Clostridium difficile or fungi.

Indexed as

Vaccinium macrocarponAgedAged, 80 and overAnimalsAnti-Bacterial AgentsChemopreventionFemaleHumansMiddle AgedPlant ExtractsSecondary PreventionTime FactorsTreatment OutcomeTrimethoprimUrinary Tract InfectionsAnti-Bacterial AgentsPlant ExtractsTrimethoprim

Identifiers

PMID19042940
PMCPMC2639265
OpenAlexW2162388969

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.